| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 606304 | 78176 | CILOSTAZOL VIR 100 MG COMPRIMIDOS EFG | CILOSTAZOL VIR 100 MG COMPRIMIDOS EFG , 70 comprimidos | 100 mg | 5 | 70 | 10 | 70 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/78176/78176_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/78176/78176_p.pdf | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 3050 | INDUSTRIA QUIMICA Y FARMACEUTICA VIR S.A. | 2013-11-12 | 1 | 1 | 1 | 2013-11-12 | 2013-11-12 | 0 | 2014-03-01 | View Edit Delete | ||||||||||||
| 604777 | 17129 | METASEDIN 5 mg COMPRIMIDOS | METASEDIN 5 mg COMPRIMIDOS, 800 comprimidos | 5 mg | 5 | 800 | 10 | 800 comprimidos | 0 | 1 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/17129/17129_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/17129/17129_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 29206 | ESTEVE PHARMACEUTICALS S.A. | 1952-05-01 | 1 | 1 | 1 | 1952-05-01 | 1998-12-01 | 1 | 2011-10-17 | Lista I | View Edit Delete | |||||||||||
| 603383 | 72280 | ATORVASTATINA MABO 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA MABO 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 500 comprimidos | 80 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72280/72280_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72280/72280_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 68134 | MABO FARMA S.A. | 2010-05-20 | 1 | 1 | 1 | 2010-05-20 | 2010-05-20 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 600140 | 62764 | OMEPRAZOL CINFAMED 20 mg CAPSULAS DURAS GASTRORESISTENTES EFG | OMEPRAZOL CINFAMED 20 mg CAPSULAS DURAS GASTRORESISTENTES EFG , 500 cápsulas | 20 mg | 5 | 500 | 43 | 500 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/62764/62764_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/62764/62764_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 1999-10-11 | 1 | 1 | 1 | 1999-10-11 | 2005-02-16 | 1 | 2024-09-09 | View Edit Delete | ||||||||||||
| 600558 | 67729 | LOSARTAN CINFA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LOSARTAN CINFA 50 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 500 comprimidos | 50 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67729/67729_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67729/67729_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2006-04-18 | 1 | 1 | 1 | 2006-04-18 | 2006-04-18 | 1 | 2024-09-09 | View Edit Delete | ||||||||||||
| 602757 | 69537 | ATORVASTATINA CINFA 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA CINFA 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 500 comprimidos | 40 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69537/69537_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69537/69537_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2008-01-22 | 1 | 1 | 1 | 2008-01-22 | 2008-01-22 | 1 | 2024-09-09 | View Edit Delete | ||||||||||||
| 605890 | 76114 | TACROLIMUS CINFA 0,5 mg CAPSULAS DURAS EFG | TACROLIMUS CINFA 0,5 mg CAPSULAS DURAS EFG, 100 cápsulas | 0,5 mg | 5 | 100 | 43 | 100 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76114/76114_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76114/76114_p.pdf | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2012-06-25 | 1 | 1 | 1 | 2018-03-16 | 2018-03-16 | 1 | 2013-04-29 | View Edit Delete | ||||||||||||
| 605891 | 76115 | TACROLIMUS CINFA 1 mg CAPSULAS DURAS EFG | TACROLIMUS CINFA 1 mg CAPSULAS DURAS EFG, 100 cápsulas | 1 mg | 5 | 100 | 43 | 100 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76115/76115_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76115/76115_p.pdf | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2012-06-25 | 1 | 1 | 1 | 2018-03-16 | 2018-03-16 | 1 | 2013-04-29 | View Edit Delete | ||||||||||||
| 605892 | 76116 | TACROLIMUS CINFA 5 mg CAPSULAS DURAS EFG | TACROLIMUS CINFA 5 mg CAPSULAS DURAS EFG, 100 cápsulas | 5 mg | 5 | 100 | 43 | 100 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/76116/76116_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/76116/76116_p.pdf | 1 | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2012-06-25 | 1 | 1 | 1 | 2018-03-16 | 2018-03-16 | 1 | 2013-04-29 | View Edit Delete | ||||||||||||
| 604728 | 50893 | FOSFOCINA 500 MG CAPSULAS DURAS | FOSFOCINA 500 MG CAPSULAS DURAS, 500 cápsulas | 500 mg | 5 | 500 | 43 | 500 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/50893/50893_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/50893/50893_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1973-02-01 | 1 | 1 | 1 | 1973-02-01 | 1973-02-01 | 0 | 2011-09-09 | View Edit Delete | ||||||||||||
| 600582 | 67789 | ENALAPRIL/HIDROCLOROTIAZIDA COMBIX 20/12,5 mg COMPRIMIDOS EFG | ENALAPRIL/HIDROCLOROTIAZIDA COMBIX 20/12,5 mg COMPRIMIDOS EFG, 500 comprimidos | 20 mg/12,5 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/67789/67789_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/67789/67789_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 12564 | LABORATORIOS COMBIX S.L.U. | 2006-05-04 | 1 | 1 | 1 | 2006-05-04 | 2006-05-04 | 1 | 2011-06-08 | View Edit Delete | ||||||||||||
| 605460 | 11691005 | ELIQUIS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ELIQUIS 2,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA, 100 comprimidos | 2,5 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/11691005/11691005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11691005/11691005_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 30842 | BRISTOL MYERS SQUIBB S.A. | 2011-06-03 | 1 | 1 | 1 | 2011-06-03 | 2011-06-03 | 1 | 2011-11-30 | View Edit Delete | ||||||||||||
| 606138 | 111691010 | ELIQUIS 5 MG COMPRIMIDO RECUBIERTO CON PELICULA | ELIQUIS 5 MG COMPRIMIDO RECUBIERTO CON PELICULA, 100 comprimidos | 5 mg | 5 | 100 | 10 | 100 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/111691010/111691010_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/111691010/111691010_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 30842 | BRISTOL MYERS SQUIBB S.A. | 2012-11-29 | 1 | 1 | 1 | 2012-11-29 | 2012-11-29 | 1 | 2013-12-26 | View Edit Delete | ||||||||||||
| 603070 | 70105 | KETOROLACO TROMETAMOL QUALIGEN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | KETOROLACO TROMETAMOL QUALIGEN 10 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 500 comprimidos | 10 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70105/70105_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70105/70105_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 30261 | NEURAXPHARM SPAIN S.L. | 2008-09-29 | 1 | 1 | 1 | 2008-09-29 | 2008-09-29 | 1 | 2012-01-02 | View Edit Delete | ||||||||||||
| 603267 | 70177 | QUETIAPINA QUALIGEN 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | QUETIAPINA QUALIGEN 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 500 comprimidos | 25 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/70177/70177_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/70177/70177_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 30261 | NEURAXPHARM SPAIN S.L. | 2008-10-24 | 1 | 1 | 1 | 2008-10-24 | 2009-11-17 | 1 | 2012-10-09 | View Edit Delete | ||||||||||||
| 603427 | 72387 | ONDANSETRON QUALIGEN 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ONDANSETRON QUALIGEN 4 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 500 comprimidos (BLISTER) | 4 mg | 5 | 500 | 10 | 500 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72387/72387_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72387/72387_p.pdf | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 30261 | NEURAXPHARM SPAIN S.L. | 2010-06-11 | 1 | 1 | 1 | 2010-06-11 | 2010-06-11 | 1 | 2015-10-07 | View Edit Delete | ||||||||||||
| 603429 | 72388 | ONDANSETRON QUALIGEN 8 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ONDANSETRON QUALIGEN 8 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 500 comprimidos (BLISTER) | 8 mg | 5 | 500 | 10 | 500 comprimidos (BLISTER) | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/72388/72388_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/72388/72388_p.pdf | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 30261 | NEURAXPHARM SPAIN S.L. | 2010-06-11 | 1 | 1 | 1 | 2010-06-11 | 2010-06-11 | 1 | 2015-10-07 | View Edit Delete | ||||||||||||
| 606715 | 54900 | ALDACTONE 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | ALDACTONE 100 mg COMPRIMIDOS RECUBIERTOS CON PELICULA , 500 comprimidos | 100 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/54900/54900_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/54900/54900_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 11622 | PFIZER S.L. | 1980-03-01 | 1 | 1 | 1 | 1980-03-01 | 1984-05-01 | 0 | 2011-02-11 | View Edit Delete | ||||||||||||
| 606741 | 80925 | ENANPLUS 75 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA | ENANPLUS 75 MG/25 MG COMPRIMIDOS RECUBIERTOS CON PELICULA 100 comprimidos (Blister PVC-PVDC/AL) | 75 mg/25 mg | 5 | 100 | 10 | 100 comprimidos (Blister PVC-PVDC/AL) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/80925/80925_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/80925/80925_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1803 | LABORATORIOS MENARINI S.A. | 2016-05-27 | 1 | 1 | 1 | 2016-05-30 | 2016-05-27 | 1 | 2016-12-13 | View Edit Delete | ||||||||||||
| 602986 | 69848 | CANDIFIX 150 mg CAPSULAS DURAS EFG | CANDIFIX 150 mg CAPSULAS DURAS EFG , 100 cápsulas | 150 mg | 5 | 100 | 43 | 100 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69848/69848_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69848/69848_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 7131 | ARAFARMA GROUP S.A. | 2008-06-04 | 1 | 1 | 1 | 2008-06-04 | 2008-06-04 | 1 | 2011-11-28 | View Edit Delete |
Page 8 of 1036, showing 20 records out of 20714 total, starting on record 141, ending on 160